Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Multicenter Study to Assess a Systematic Screening of Occupational Exposures in Lung Cancer Patients.
Pérol O, Lepage N, Noelle H, Lebailly P, de Labrusse B, Clin B, Boulanger M, Praud D, Fournié F, Galvaing G, Dutheil F, Le Meur B, Serin D, Dansin E, Nisse C, Charbotel B, Fervers B. Pérol O, et al. Among authors: dansin e. Int J Environ Res Public Health. 2023 Mar 13;20(6):5068. doi: 10.3390/ijerph20065068. Int J Environ Res Public Health. 2023. PMID: 36981979 Free PMC article.
[Bronchial anthracosis and pulmonary mica overload].
Mulliez P, Billon-Galland MA, Dansin E, Janson X, Plisson JP. Mulliez P, et al. Among authors: dansin e. Rev Mal Respir. 2003 Apr;20(2 Pt 1):267-71. Rev Mal Respir. 2003. PMID: 12844024 French.
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group.
Giaccone G, Smit EF, de Jonge M, Dansin E, Briasoulis E, Ardizzoni A, Douillard JY, Spaeth D, Lacombe D, Baron B, Bachmann P, Fumoleau P; EORTC-New Drug Development Group. Giaccone G, et al. Among authors: dansin e. Eur J Cancer. 2004 Mar;40(5):667-72. doi: 10.1016/j.ejca.2003.10.027. Eur J Cancer. 2004. PMID: 15010066 Clinical Trial.
Phase I dose-escalation study of oral vinflunine in combination with erlotinib in pre-treated and unselected EGFR patients with locally advanced or metastatic non-small-cell lung cancer.
Krzakowski M, Bennouna J, Dansin E, Kowalski D, Hiret S, Penel N, Favrel S, Tourani JM. Krzakowski M, et al. Among authors: dansin e. Cancer Chemother Pharmacol. 2014 Feb;73(2):231-6. doi: 10.1007/s00280-013-2342-3. Epub 2013 Nov 13. Cancer Chemother Pharmacol. 2014. PMID: 24220936 Free PMC article. Clinical Trial.
Randomized multicenter phase II study of larotaxel (XRP9881) in combination with cisplatin or gemcitabine as first-line chemotherapy in nonirradiable stage IIIB or stage IV non-small cell lung cancer.
Zatloukal P, Gervais R, Vansteenkiste J, Bosquee L, Sessa C, Brain E, Dansin E, Urban T, Dohollou N, Besenval M, Quoix E. Zatloukal P, et al. Among authors: dansin e. J Thorac Oncol. 2008 Aug;3(8):894-901. doi: 10.1097/JTO.0b013e31817e6669. J Thorac Oncol. 2008. PMID: 18670308 Free article. Clinical Trial.
99 results